DK144947B - ANALOGY PROCEDURE FOR PREPARING D-HOMOPREGNA-4,16-DIEN-3,20-DIONES - Google Patents
ANALOGY PROCEDURE FOR PREPARING D-HOMOPREGNA-4,16-DIEN-3,20-DIONES Download PDFInfo
- Publication number
- DK144947B DK144947B DK32077A DK32077A DK144947B DK 144947 B DK144947 B DK 144947B DK 32077 A DK32077 A DK 32077A DK 32077 A DK32077 A DK 32077A DK 144947 B DK144947 B DK 144947B
- Authority
- DK
- Denmark
- Prior art keywords
- diene
- dione
- hydroxy
- homopregna
- general formula
- Prior art date
Links
Landscapes
- Steroid Compounds (AREA)
Description
(19) DANMARK(19) DENMARK
- FREMLÆGGELSÉSSKfilFT (1.) 1^4947 B- PRESENTATION Fil (1) 4947 B
DIREKTORATET FOR PATENT- OG VAREMÆRKEVÆSENETDIRECTORATE OF THE PATENT AND TRADEMARKET SYSTEM
(21) Ansøgning nr. 320/77 (54) |nt.Cl.a C 07 J 63/00 (22) Indleveringsdag 2β. jan. 1977 (24) Løbedag 24. raar. 1975 (41) Aim. tilgængelig 26. jan. 1977 (44) Fremlagt 12. jul. 1982 (86) International ansøgning nr. - (86) International indleveringsdag (85) Videreførelsesdag - (62) Stamansøgning nr. 1230/75 (30) Prioritet 7. okt. 1974, 13424/74, CH 2. dec. 1974, 15950/74, CH " (71) Ansøger F. HOFMANN-1A ROCHE & CO. MTIENGESELLSCHAFT, CH-4002(21) Application No. 320/77 (54) | nt.Cl.a C 07 J 63/00 (22) Filing Day 2β. Jan. 1977 (24) Race day 24. strange. 1975 (41) Aim. available Jan 26 1977 (44) Presented 12 Jul. 1982 (86) International application no. - (86) International filing day (85) Continuation day - (62) Master application no. 1230/75 (30) Priority 7 Oct. 1974, 13424/74, CH Dec 2 1974, 15950/74, CH "(71) Applicant F. HOFMANN-1A ROCHE & CO. MTIENGESELLSCHAFT, CH-4002
Basel, CH. .Basel, CH. .
(72) Opfinder Leo Alig, CH: Andor Fuerst, CH: Marcel Mueller, CH: Ulrich Kerb, DE: Rudolf Wiechert, DE.(72) Inventor Leo Alig, CH: Andor Fuerst, CH: Marcel Mueller, CH: Ulrich Kerb, DE: Rudolf Wiechert, DE.
(74) Fuldmægtig plougmann & Vingtoft Patentbureau.(74) Plougmann & Vingtoft Patent Bureau.
(54) Analogifremgangsmåde til frem= stilling af D-homopregna-4,1 6-di= en-3i 20-dioner.(54) Analogous procedure for preparing D-homopregna-4,1 6-di = en-3i 20-dione.
Den foreliggende opfindelse angår en analogifremgangsmåde til fremstilling af hidtil ukendte D-homoprégna-4,16-dien-3,20-dioner med den almene formel IThe present invention relates to an analogous process for the preparation of novel D-homopregna-4,16-diene-3,20-dione of the general formula I
R21CH„ ^0.R21CH2.
Rl m 2 r10| j! K jl JL li iRl m 2 r10 | j! K jl JL li i
cn >· Icn> · I
* R6* R6
OISLAND
1 o hvor R og R betegner hydrogen eller tilsammen la,2a-methylen eller en carbon-carbon-binding, R6 betegner hydrogen, fluor, chlor eller methyl, R17a betegner acyloxy med højst 15 carbonatomer, R10 betegner methyl eller, såfremt R1 og R2 betegner hydrogen, til lige hydrogen, og R21 betegner hydrogen, fluor eller chlor.Wherein R and R represent hydrogen or together la, 2a-methylene or a carbon-carbon bond, R6 represents hydrogen, fluorine, chlorine or methyl, R17a represents acyloxy of not more than 15 carbon atoms, R10 represents methyl or, if R 1 and R 2 represents hydrogen, to equal hydrogen, and R21 represents hydrogen, fluorine or chlorine.
2 1449472 144947
En acyloxygruppe er afledt at en mættet eller umættet aliphatisk carboxylsyre eller af en cycloaliphatisk, araliphatisk eller aromatisk carboxylsyre med højst 15 carbonatomer. Eksempler på sådanne syrer er myresyre, eddikesyre, pivalinsyre, propionsyre, smør- . syre, capronsyre, enanthsyre, undecylensyre, oliesyre, cyclopentyl-propionsyre, cyclohexylpropionsyre, phenyleddikesyre og benzoesyre.An acyloxy group is derived from a saturated or unsaturated aliphatic carboxylic acid or from a cycloaliphatic, araliphatic or aromatic carboxylic acid having a maximum of 15 carbon atoms. Examples of such acids are formic acid, acetic acid, pivalic acid, propionic acid, butter. acid, capric acid, enanthic acid, undecylenic acid, oleic acid, cyclopentylpropionic acid, cyclohexylpropionic acid, phenylacetic acid and benzoic acid.
Der.foretrækkes især alkanoyloxygrupper med 1-7 carbonatomer.Particularly preferred are alkanoyloxy groups having 1-7 carbon atoms.
En i 6-stillingen siddende substituent kan have a- eller β-konfigura-tion. a-Isomerene foretrækkes.A substituent seated in the 6-position may have α or β configuration. The α-isomers are preferred.
Fremgangsmåden ifølge opfindelsen til fremstilling af D-homopregna-4,16--dien-3,20-dioner med den almene formel I er ejendommelig ved, at manThe process of the invention for the preparation of D-homopregna-4,16 - diene-3,20-dione of the general formula I is characterized in that:
a) i et D-homosteroid med den almene formel IIa) in a D-homosteroid of the general formula II
r21chs^ ^</.R17a R61 hvor R^ betegner hydrogen eller methyl, og R"*-73 og R2^ har den ovenfor anførte betydning, oxiderer 3-hydroxy-/\.^-grupperingen λ 4 til en 3-keto-/\ -gruppering, eller b) fluorerer eller chlorerer et D-homosteroid med den almene formelwherein Rchs represents hydrogen or methyl, and R * 73 - 73 and R₂ ^ have the meaning given above, the 3-hydroxy - /. 4 group oxidizes λ 4 to a 3-keto group. / b grouping, or b) fluorinating or chlorinating a D-homosteroid of the general formula
IIIIII
3 144947 r21ch2 ..0 r1 ^1>-I7a R2 ^ JL jj 111 hvor R / R , R , R og R har den ovenfor anførte betydning/ i 6-stillingen, ogf om ønsket/ isomeriserer en vunden 6β—isomer til den 6a-isomere, eller c) methylerer et D-homosteroid med den almene formel iv r21cH2N^-° r1 x."R17a hvor R , R , R , R og R har den ovenfor anførte betydning/ i 6-stillinqen, ellerWherein R / R, R, R and R are as defined above in the 6-position, and if desired, a 6β-isomer is obtained / isomerized to the 6a isomers, or c) methylates a D-homosteroid of the general formula iv r21cH2N2 - ° r1 x. "R17a wherein R, R, R, R and R are as defined above / in the 6-position, or
d) acylerer hydroxygruppen i et D-homosteroid med den almene formel Vd) acylating the hydroxy group of a D-homosteroid of the general formula V
R21CH2'0R21CH2'0
,1 /-vJr0H, 1 / -vJr0H
4 144947 hvor R1, R2, R6, R10 og R-1 har den ovenfor anførte betydning, eller4, 144947 wherein R1, R2, R6, R10 and R-1 are as defined above, or
e) hydrolyserer et D-homosteroid med den almene formel VIe) hydrolyzing a D-homosteroid of general formula VI
R21CH \^-°R21CH \ - °
I U VII U VI
' A ! B i hvor R^a og R2^ har den ovenfor anførte betydning, X betegner en over nitrogen, oxygen eller svovl til ringsystemet bundet organisk gruppe, og der forekommer mindst én af de i ringene A og B med de 4 stiplede linjer angivne bindinger, under dannelse af en -3-keton.'A! B in which R 1a and R 2 have the meaning given above, X represents an organic group attached to the ring system with nitrogen, oxygen or sulfur and at least one of the bonds listed in rings A and B with the 4 dotted lines is present; to form a -3 ketone.
Oxidationen af en forbindelse med formlen II (fremgangsmådevariant a) kan udføres efter Oppenauer, f.eks. ved hjælp af aluminiumiso- propylat, eller med oxidationsmidler såsom chromtrioxid (f.eks.The oxidation of a compound of formula II (process variant a) can be carried out after Oppenauer, e.g. by aluminum isopropylate, or with oxidizing agents such as chromium trioxide (e.g.
Jones' reagens) eller efter Pfitzner-Moffatt ved hjælp af dimethyl- sulfoxid/dicyclohexylcarbodiimid (hvorhos den primært vundne -keton derefter må isomeriseres til dannelse af en /\^-3"keton)t eller ved hjælp af pyridin/SO-*. Ved anvendelse af et af de ovenfor anførte J 4 oxidationsmidler fås en 3-keto-A -gruppering.Jones' reagent) or after Pfitzner-Moffatt by dimethylsulfoxide / dicyclohexylcarbodiimide (the primary ketone then obtained is then isomerized to form a 3-ketone) t or by pyridine / SO- *. Using one of the J 4 oxidants listed above, a 3-keto-A group is obtained.
Halogeneringen i 6-stillingen (fremgangsmådevariant o) udføres fortrinsvis ved, at et D-homosteroid med formlen III omdannes til en 3-enolester eller 3-enolether, f.eks. 3-enolacetatet, og derefter omsættes med chlor [jfr. J.Am.Chem.Soc. 82, 1230 (I960)], med et N--halogenimid [jfr. J.Am.Chem.Soc. £12, 1230 (1960); TJ_, 3827 (1955)] eller perchlorylfluorid [jfr. J.Am.Chem.Soc. 81, 5259 (1959)]; Chem. and Ind. 1959, 1317]. Som fluoreringsmidler kan der endvidere anvendes trifluormethylhypofluorit.The halogenation at the 6-position (process variant o) is preferably carried out by converting a D-homosteroid of formula III into a 3-enol ester or 3-enol ether, e.g. 3-enol acetate, and then react with chlorine [cf. J. Am. 82, 1230 (I960)], with an N - halogenimide [cf. J. Am. £ 12, 1230 (1960); TJ_, 3827 (1955)] or perchloryl fluoride [cf. J. Am. 81, 5259 (1959)]; Chem. and Ind. 1959, 1317]. Also, as fluorinating agents, trifluoromethyl hypofluorite can be used.
Chloreringen kan endvidere foretages ved hjælp af chromylchlorid i methylenchlorid-eller ethere. .The chlorination can also be carried out by means of chromyl chloride in methylene chloride or ethers. .
5 144947 Såfremt der ved de ovenfor beskrevne halogeneringer dannes isomer-blandinger, dvs. blandinger af 6a- og 6£3-halogensteroider, kan disse opspaltes i de rene isomere efter kendte metoder, f.eks. chroma-tografi.If the halogenations described above form isomer mixtures, i.e. mixtures of 6α and 6β-halo steroids, these can be cleaved into the pure isomers by known methods, e.g. chroma chromatography.
Isomeriseringen af et vundet 6B-halogen-D-homosteroid, især en ββ-fluor- eller -chlorforbindelse* kan foretages ved behandling med en syre, især en mineralsyre såsom saltsyre, eller brombrintesyre i et opløsningsmiddel-, f.eks? dioxan eller iseddike.The isomerization of a 6B halogen-D homosteroid obtained, in particular a β-fluorine or chlorine compound * can be carried out by treatment with an acid, especially a mineral acid such as hydrochloric acid, or hydrochloric acid in a solvent, e.g. dioxane or glacial acetic acid.
Methyleringen ifølge fremgangsmådevariant c) kan f.eks. udføres ved omdannelse af udgangsforbindelsen med formlen IV til en 3-enolether (f.eks. ved behandling med en orthomyresyreester, f.eks. orthomyre-syreethylester, i nærværelse af en syre, f.eks. p-toluensulfonsyre, eventuelt under tilsætning af den tilsvarende alkohol; eller ved behandling af udgangsforbindelsen IVmed en dialkoxypropan, f.eks.The methylation according to process variant c) can e.g. is carried out by converting the starting compound of formula IV into a 3-enol ether (for example, by treatment with an ortho-acid ester, eg orthomyric acid ethyl ester, in the presence of an acid, e.g. p-toluenesulfonic acid, optionally with or by treating the starting compound IV with a dialkoxypropane, e.g.
2,2-dimethoxypropan i methanol-dimethylformamid i nærværelse af p- τ -toluensulfonsyre) og omsætning af enoletheren med en tetrahalogen-methan, f.eks. CBr^, CC^Brj eller CCl^Br til dannelse af trihalo-genmethyl-A^~3-ketonen. Trihalogenmethyl-/\^~3-ketonen kan dehydro-halogeneres med baser såsom collidin til dannelse af dihalogen- 4 methylen-/^ -3-keton, som på sin side ved katalytisk hydrogenering under milde betingelser, f.eks. med en palladium/strontiumcarbo-nat-katalysator, kan omdannes til 6a-methyl-/\4~3-ketonen.2,2-dimethoxypropane in methanol-dimethylformamide in the presence of p-τ -toluenesulfonic acid) and reaction of the enol ether with a tetrahalogen-methane, e.g. CBr ^, CC ^ Brj or CCl ^ Br to form the trihalo gene methyl A? ~ 3 ketone. The trihalomethyl / β-ketone can be dehydrohalogenated with bases such as collidine to form dihalo-4-methylene / β-3-ketone, which, in turn, by catalytic hydrogenation under mild conditions, e.g. with a palladium / strontium carbonate catalyst, can be converted to the 6α-methyl - [4 ~ 3 ketone.
For forbindelser med formlen IV, hvor R^" = R^ = hydrogen, består en fordelagtig methyleringsmetode i, at en sådan forbindelse med formlen IV på den ovenfor beskrevne måde omdannes til en 3-enolether, og denne på i og for sig kendt måde omsættes til dannelse af et tilsvarende 6-formylderivat, formylgruppen reduceres ved hjælp af natriumbor-hydrid til en hydroxymethylgruppe, og reaktionsproduktet derefter under spaltning af enoletheren dehydratiseres, hvorved der fås et 6 U4947For compounds of formula IV, wherein R 2 = R 2 = hydrogen, an advantageous methylation method consists in converting such a compound of formula IV in the manner described above into a 3-enol ether, and in a manner known per se. is reacted to form a corresponding 6-formyl derivative, the formyl group is reduced by sodium borohydride to a hydroxymethyl group, and the reaction product is then dehydrated during cleavage of the enol ether to give a 6 U4947
D-homosteroid med den almene formal VIID-homosteroid with the general formula VII
R21™,^0 Τ'*173 *iorf\R21 ™, ^ 0 Τ '* 173 * iorf \
I JJ VIIIn JJ VII
JJy CH2 hvor R^, R^ og R^a har den ovenfor anførte betydning.Where R 2, R 2 and R 2 a have the meaning given above.
6-Methylen-mellemprodukter kan også fremstilles ved omdannelse af forbindelser med formlen IVtil en 3-enamin, f.eks. 3-pyrrolidi-niumenamin, hydroxymethylering med formaldehyd og vandfraspaltning ved hjælp af syrer såsom p-toluensulfonsyre.6-Methylene intermediates may also be prepared by converting compounds of formula IV into a 3-enamine, e.g. 3-pyrrolidinium enamine, hydroxymethylation with formaldehyde and water decomposition by acids such as p-toluenesulfonic acid.
6-Methylen-mellemprodukterne kan på sædvanlig måde ved hjælp af kendte hydrogeneringskatalysatorer hydrogeneres til dannelse af de tilsvarende 6-methylforbindelser.The 6-methylene intermediates may be hydrogenated in the usual manner by known hydrogenation catalysts to form the corresponding 6-methyl compounds.
Acyleringen af 17a-hydroxygruppen i et D-homosteroid med formlen V (fremgangsmådevariant d) kan udføres på i og for sig kendt måde ved behandling med et reaktivt syrederivat, f.eks. et acylhalogenid eller -anhydrid i nærværelse af p-N,N~dimethylamino- pyridin.The acylation of the 17α-hydroxy group in a D-homosteroid of formula V (process variant d) can be carried out in a manner known per se by treatment with a reactive acid derivative, e.g. an acyl halide or anhydride in the presence of p-N, N-dimethylamino-pyridine.
Hydrolysen af den i 3-stillingen værende substituent i et D-homosteroid med formlen VI ved fremgangsmådevariant e) kan udføres på i og for sig kendt måde ved hjælp af syrer, f.eks. mineralsyrer såsom saltsyre, eller med carboxylsyrer såsom oxalsyre. Som reaktionsmedium kan især anvendes alkoholiske eller vandig-alkoholiske opløsninger, f.eks. methanol eller methanol/vand, som eventuelt yderligere opløsningsmidler, f.eks. chloroform.The hydrolysis of the substituent at the 3-position of a D-homosteroid of formula VI by process variant e) can be carried out in a manner known per se by means of acids, e.g. mineral acids such as hydrochloric acid, or with carboxylic acids such as oxalic acid. Particularly alcoholic or aqueous-alcoholic solutions, e.g. methanol or methanol / water, as optional additional solvents, e.g. chloroform.
Eksempler på D-homosteroider med formlen VI er sådanne, i hvilke X sammen med dobbeltbindingssystemet i ring. A og/eller B danner en 3-alkoxy-(f.eks. methoxy-)~/\2'^; 3-alkylthio-(f.eks. 3-methyl-thio-)-/\2f ** . 3-sek.amino - (f .eks. pyrrolidino-) ~/\2 ’ ; 3-alkylendioxy-(f .eks. ethylendioxy-)-/\^ -, /eller /\^~; 7 1U947 eller en 3-alkylendithio- (f. eks . ethylendithio-.) -/\^ , £\- 5 eller /\^ -gruppering.Examples of D-homosteroids of formula VI are those in which X together with the double bond system in ring. A and / or B form a 3-alkoxy- (e.g., methoxy-) - [2] 2; 3-alkylthio- (eg 3-methylthio-) - / 2f **. 3-sec.amino - (e.g., pyrrolidino-) ~ / 2 '; 3-alkylenedioxy- (e.g., ethylenedioxy -) - / -, - or / / Or a 3-alkylenedithio (e.g. ethylene dithio), β, β or β group.
En særlig foretrukken udførelsesform for fremgangsmåden ifølge opfindelsen går ud på, at der fremstilles forbindelser med formlen I, hvor R^ og R^ er hydrogen, R^ er hydrogen eller methyl, R^7a er al-kanoyloxy med 1-7 carbonatomer, og R er hydrogen, da der derved fås forbindelser, som er særlig foretrukne på grund af deres særlig kraftige virkning.A particularly preferred embodiment of the process of the invention is that compounds of formula I are prepared in which R 1 and R 2 are hydrogen, R 2 is hydrogen or methyl, R 7a is al-canoyloxy of 1-7 carbon atoms, and R is hydrogen, thereby providing compounds which are particularly preferred because of their particularly potent action.
De ved fremgangsmåden ifølge opfindelsen som udgangsmaterialer anvendte D-homosteroider kan, såfremt deres fremstilling ikke her er beskrevet, fremstilles i analogi med de i eksemplerne anførte metoder.The D-homosteroids used in the process according to the invention as starting materials, if their preparation is not described herein, can be prepared by analogy to the methods set forth in the examples.
Forbindelserne med formlen I har hormonal virkning, især på det endokrine system, og de er ejendommelige ved selektivitet i virkningen. De kan derfor anvendes som hormonalt virksomme midler, f.eks. som progestativa, og de kan administreres oralt eller paren-teralt. Som doseringsretningslinje kan anføres 0,005 mg/kg - 0,15 mg/kg pr. dag.The compounds of formula I have hormonal action, especially on the endocrine system, and are peculiar to selectivity in action. They can therefore be used as hormonally active agents, e.g. as progestatives and may be administered orally or parenterally. 0.005 mg / kg - 0.15 mg / kg per dosage guideline day.
De omhandlede forbindelser med formlen I er nært beslægtede, for deres gestagene virkning kendte forbindelser overlegne i Clauberg--testen på kaniner, hvilket fremgår af de nedenfor anførte McPhail--værdier: 8 144947The compounds of formula I are closely related, for their progestogenic effect, known compounds are superior in the Clauberg test to rabbits, as shown by the McPhail values given below: 8 144947
Gestagen virkning i Clauberg-test.Gestagenic effect in Clauberg test.
Forbindelse Dosis (mg) McPhail- Sammenlignings- -indeks forbindelse 17aa-acetoxy-D-homo- 0,1 subcutant 3,3 3,0 19-nor-acetoxy- -19-nor-4,16-pregna- 0,03 subcutant 3,2 2,5 -progesteron dien-3,20-dion 0,01 subcutant 2,7 1,3 17 aa-acetoxy-D-homo- 0,1 subcutant 3,3 2,4 acetoxyprogeste- pregna-4,16-dien- 0,03 subcutant 2,2 1,1 ron -3,20-dion 0,01 subcutant 1,4 1 17aa-acetoxy-6a-me- 0,1 peroralt 2,5 1,1 "Provera" ® thy1-D-homopregna- 0,03 peroralt 1,2 1,0 -4,16-dien-3,20-dion ab ajr 17aa-hexanoyloxy-D- 3 subcutant 3,7^ 2,4^ progesteron- -homopregna-4,16-dien- 1 subcutant 2,9* Ir4** capronat -3,20-clion 3 subcutant 2,2* 1,2* 1 subcutant 1,6* 1,2* * 8 dage efter injektion fcfc 12 dage efter injektionCompound Dose (mg) McPhail Comparative Index Compound 17aa-Acetoxy-D-Homo 0.1 Subcutaneously 3.3 3.0 19-nor-acetoxy-19-nor-4,16-pregna-0.03 subcutaneous 3.2 2,5-progesterone diene-3,20-dione 0.01 subcutaneous 2.7 1.3 17 aa-acetoxy-D-homo 0.1 subcutaneous 3.3 2.4 acetoxyprogeste-pregna-4 , 16-diene 0.03 subcutaneous 2.2 1.1 ron -3.20-dione 0.01 subcutaneously 1.4 1 17aa-acetoxy-6a-0.1 0.1 oral 2.5 1.1 "Provera Thy1-D-homopregna- 0.03 peroral 1.2 1.0 -4.16-diene-3,20-dione ab aj 17aa-hexanoyloxy-D-3 subcutaneously 3.7 ^ 2.4 ^ progesterone -homopregna-4,16-diene-1 subcutaneous 2,9 * Ir 4 ** capronate -3,20-clion 3 subcutaneously 2.2 * 1.2 * 1 subcutaneously 1.6 * 1.2 * * 8 days after injection fcfc 12 days after injection
Forbindelserne med formlen I skal anvendes som lægemidler, f.eks. i form af farmaceutiske præparater, som indeholder dem i blanding med et til enteral, percutan eller parenteral applikation egnet organisk eller uorganisk inert bærestof.The compounds of formula I should be used as drugs, e.g. in the form of pharmaceutical compositions containing them in admixture with an organic or inorganic inert carrier suitable for enteral, percutaneous or parenteral application.
Fremgangsmåden ifølge opfindelsen belyses nærmere ved nedenstående eksempler:The process according to the invention is further illustrated by the following examples:
Eksempel 1.Example 1.
Til 440 mg 17aa-acetoxy-3(i-hydroxy-D-homopregna-5,16-dien-20-on i 30 ml acetone sættes 0,55 ml Jones' reagens, der omrøres i 5 minutter, hældes ud i vand og ekstraheres med methylenchlorid. Methylenchlorid- 9 1U947 opløsningerne vaskes med vand, tørres og inddampes. Den vundne olie udrøres i 8 ml dioxan og 0,8 ml 2N saltsyre i 1 time ved stuetemperatur. Blandingen inddampes, og remanensen chromatograferes på sili-cagel. Det vundne 17aa-acetoxy-D-homopregna-4,16-dien-3,20-dion smelter ved 222 - 223°C (acetone-hexan).To 440 mg of 17aa-acetoxy-3 (i-hydroxy-D-homopregna-5,16-diene-20-one in 30 ml of acetone is added 0.55 ml of Jones' reagent, which is stirred for 5 minutes, poured into water and The methylene chloride solutions are washed with water, dried and evaporated. 17aa-acetoxy-D-homopregna-4,16-diene-3,20-dione melted at 222 - 223 ° C (acetone-hexane).
Fremstilling af udgangsmaterialet: 33,17aa-dihydroxy-D-homopregna-5,16-dien-20-on omsættes i eddikesyre- anhydrid og triethylamin i nærværelse af p-N,N-dimethylaminopyridin til dannelse af 33,17aa-diacetoxy-D-homopregna-5,16-dien-20-on (smeltepunkt 179 - 180°C, [a]D = -273°, c = 0,1% i dioxan), og dette hydrolyseres derefter partielt med potaske i methanol til dannelse af 17a a-acetoxy-30-hydroxy-D-homopregna-5,16-dien-20-on.Preparation of the starting material: 33,17aa-dihydroxy-D-homopregna-5,16-dien-20-one is reacted in acetic anhydride and triethylamine in the presence of pN, N-dimethylaminopyridine to form 33,17aa-diacetoxy-D-homopregna -5,16-diene-20-one (m.p. 179-180 ° C, [α] D = -273 °, c = 0.1% in dioxane) and this is then partially hydrolyzed with potash in methanol to give 17a a-acetoxy-30-hydroxy-D-homopregna-5,16-dien-20-one.
Eksempel 2.Example 2.
4,65 g 17a-a-hydroxy-D-homopregna-4,16-dien-3,20-dion og 1,55 g p-N,N- -dimethylaminopyridin omrøres under argonatmosfære i 23,5 ml triethylamin og 14,5 ml eddikesyreanhydrid i 16 timer ved stuetemperatur. Blandingen hældes ud i iskold fortyndet saltsyre og ekstraheres med methylenchlorid. Methylenchloridopløsningerne vaskes neutrale med fortyndet natriumhydrogencarbonatopløsning og fortyndet kogsaltopløsning, tørres og inddampes. Ved chromatografi af råproduktet på sili-cagel og to ganges krystallisation af acetone-hexan fås 17aa-acetoxy--D-homopregna-4,16-dien-3,20-dion med smeltepunkt 223 - 224°C; UV-spektrum: ^240 ~ 16800i [a)D = “134° (c =0,1% i dioxan).4.65 g of 17α-α-hydroxy-D-homopregna-4,16-diene-3,20-dione and 1.55 g of pN, N- dimethylaminopyridine are stirred under argon atmosphere in 23.5 ml of triethylamine and 14.5 ml acetic anhydride for 16 hours at room temperature. The mixture is poured into ice-cold dilute hydrochloric acid and extracted with methylene chloride. The methylene chloride solutions are washed neutral with dilute sodium bicarbonate solution and dilute brine, dried and evaporated. Chromatography of the crude product on silica gel and two-fold crystallization of acetone-hexane gives 17aa-acetoxy-D-homopregna-4,16-diene-3,20-dione, mp 223 - 224 ° C; UV Spectrum: ^ 240 ~ 16800i [a) D = " 134 ° (c = 0.1% in dioxane).
Udgangsmaterialet kan fremstilles ved oxidation af 3(3-hydroxy-D--homopregna-5,17-dien-20-on i dimethylformamid og tetrahydrofuran i nærværelse af kalium-tert.butylat og trimethylphosphit med oxygen til dannelse af 33,17aa-dihydroxy-D-homopregna-5,16-dien-20-on. Smeltepunkt 241 - 243°C; [ο]β = -187° (c = 0,1% i dioxan). Ved oxidation ifølge Pfitzner-Moffatt fås herudfra 17aa-hydroxy-D-homopregna--4,16-dien-3,20-dion med smeltepunkt 177 - 178°C; UV-spektrum: e24Q = 16800; [a)D = +18° (c = 0,1% i dioxan).The starting material can be prepared by oxidation of 3 (3-hydroxy-D - homopregna-5,17-diene-20-one in dimethylformamide and tetrahydrofuran in the presence of potassium tert.butylate and trimethylphosphite with oxygen to give 33.17aa-dihydroxy -D-homopregna-5,16-diene-20-one Melting point 241 - 243 ° C; [ο] β = -187 ° (c = 0.1% in dioxane). By Pfitzner-Moffatt oxidation, 17aa is obtained -hydroxy-D-homopregna - 4,16-diene-3,20-dione, m.p. 177 - 178 ° C; UV Spectrum: e24Q = 16800; [a) D = + 18 ° (c = 0.1% in dioxane).
10 14494710 144947
Eksempel 3.Example 3
396 mg 17aa-acetoxy-6-methylen-D-homopregna-4,16-dien-3,20-dion og 396 mg palladium/calciumcarbonat hydrogeneres i 39,6 ml toluen, indtil der er optaget en ækvivalent mængde hydrogen. Katalysatoren fra-filtreres, filtratet inddampes, og remanensen omrøres i 10 ml dioxan og 1 ml 2N saltsyre i 1 time ved stuetemperatur. Opløsningen inddampes, og remanensen renses på en lille mængde silicagel. Der fås 17aa-acetoxy-6a-methyl-D-homopregna-4,16-dien-3,20-dion med smeltepunkt 216 - 218°C, Ca]D = -136° (c = 0,1 i dioxan), UV-spektrum: ^241 ~ 14600.396 mg of 17aa-acetoxy-6-methylene-D-homopregna-4,16-diene-3,20-dione and 396 mg of palladium / calcium carbonate are hydrogenated in 39.6 ml of toluene until an equivalent amount of hydrogen is taken up. The catalyst is filtered off, the filtrate is evaporated and the residue is stirred in 10 ml of dioxane and 1 ml of 2N hydrochloric acid for 1 hour at room temperature. The solution is evaporated and the residue is purified on a small amount of silica gel. 17aa-acetoxy-6a-methyl-D-homopregna-4,16-diene-3,20-dione is obtained, mp 216 - 218 ° C, Ca] D = -136 ° (c = 0.1 in dioxane), UV Spectrum: ^ 241 ~ 14600.
Udgangsmaterialet kan fremstilles på følgende måde: 17ao-Acetoxy-D-homopregna-4/16-dien-3,20-dion omsættes i methanol i varmen med pyrrolidin. Der fås 17aa-acetoxy-3-pyrrolidino-D-homopreg-na-3,5,16-trien-20-on, som omsættes med vandig formaldehydopløsning i alkohol og benzen til dannelse af 17aa-acetoxy-6-hydroxymethyl-D--homopregna-4,16-dien-3,20-dion, smeltepunkt 224 - 226°C (acetone--hexan),The starting material can be prepared as follows: 17α-Acetoxy-D-homopregna-4/16-diene-3,20-dione is reacted in methanol in the heat with pyrrolidine. 17aa-acetoxy-3-pyrrolidino-D-homopreg-na-3,5,16-triene-20-one is obtained, which is reacted with aqueous formaldehyde solution in alcohol and benzene to give 17aa-acetoxy-6-hydroxymethyl-D -homopregna-4,16-diene-3,20-dione, m.p. 224 - 226 ° C (acetone-hexane),
Ved behandling deraf med saltsyre i dioxan fås 17aa-acetoxy-6-methylen--D-homopregna-4,16-dien-3,20-dion med smeltepunkt 211 - 213°C (acetone--hexan) ; UV-spektrum: ''251 = 10800, [aj^ = -13° (c = 0,1% i dioxan).Upon treatment thereof with hydrochloric acid in dioxane, 17aa-acetoxy-6-methylene-D-homopregna-4,16-diene-3,20-dione is obtained, mp 211 - 213 ° C (acetone - hexane); UV spectrum: 251 = 10800, [α] D = -13 ° (c = 0.1% in dioxane).
Eksempel 4.Example 4
En opløsning af 3,2 g 17aa-acetoxy-6-dibrom-methylen-D-homopregna-“4,16-dien-3,20-dion i 60 ml dioxan og 2,5 ml triethylamin hydrogeneres ved hjælp af 5 g 2%'s palladium/strontiumcarbonat-katalysator, indtil der er optaget tre ækvivalenter hydrogen. Katalysatoren fra-filtreres, og filtratet syrnes til pH-værdi 1 ved tilsætning af 2N saltsyre, hvorved det vundne 17aa-acetoxy-6p-methyl-D-homopregna-4,16--dien-3,20-dion isomeriseres til dannelse af den tilsvarende 6a--methylforbindelse. Blandingen lades henstå i 2 timer ved stuetemperatur, tilsættes vand og ekstraheres med methylenchlorid. De organiske ekstrakter vaskes neutrale med natriumhydrogencarbonatopløsning og vand, tørres med natriumsulfat og inddampes i vakuum. Remanensen 11 144947 chromatograferes på silicagel, og de chromatografisk rene fraktioner omkrystalliseres af acetone-hexan. Der fås rent 17aa-acetoxy-6a--methyl-D-homopregna-4,16-dien-3,20-dion, smeltepunkt 216 - 218°C/ UV-spektrum: e2H ~ 14600, [a]D = -136° (e = 0,1% i dioxan) .A solution of 3.2 g of 17aa-acetoxy-6-dibromo-methylene-D-homopregna- 4,16-diene-3,20-dione in 60 ml of dioxane and 2.5 ml of triethylamine is hydrogenated with 5 g of 2 % palladium / strontium carbonate catalyst until three equivalents of hydrogen are taken up. The catalyst is filtered off and the filtrate is acidified to pH 1 by the addition of 2N hydrochloric acid, whereby the 17aa-acetoxy-6β-methyl-D-homopregna-4,16-diene-3,20-dione isomerized to give the corresponding 6a - methyl compound. The mixture is allowed to stand for 2 hours at room temperature, water is added and extracted with methylene chloride. The organic extracts are washed neutral with sodium bicarbonate solution and water, dried with sodium sulfate and evaporated in vacuo. The residue 11 is chromatographed on silica gel and the chromatographically pure fractions are recrystallized from acetone-hexane. Pure 17aa-acetoxy-6a-methyl-D-homopregna-4,16-diene-3,20-dione is obtained, m.p. 216 - 218 ° C / UV spectrum: e2H ~ 14600, [a] D = -136 ° (e = 0.1% in dioxane).
Udgangsmaterialet kan fremstilles på følgende måde: 17aa-Acetoxy-D-homopregna-4,16-dien-3,20-dion omsættes i dioxan med orthomyresyremethylester i nærværelse af p-toluensulfonsyre og noget methanol til dannelse af 17aa-acetoxy-3-methoxy-D-homopregna-3,5,16--trien-20-on, smeltepunkt 185 - 187°C.The starting material can be prepared as follows: 17aa-Acetoxy-D-homopregna-4,16-diene-3,20-dione is reacted in dioxane with orthoformic acid methyl ester in the presence of p-toluenesulfonic acid and some methanol to give 17aa-acetoxy-3-methoxy -D-homopregna-3,5,16 - triene-20-one, m.p. 185 - 187 ° C.
Denne enolether omsættes i collldin med tetrabrommethan i 80 timer til dannelse af 17aa-acetoxy-6-tribrommethyl-D-homopregna-4,16-dien--3,20-dion. Denne omdannes ved opvarmning i pyridin til 17aa-acet-oxy-6-dibrommethylen-D-homopregna-4,16-dien-3,20-dion.This enol ether is reacted in colldine with tetrabromomethane for 80 hours to give 17aa-acetoxy-6-tribromomethyl-D-homopregna-4,16-diene-3,20-dione. This is converted by heating in pyridine to 17aa-acet-oxy-6-dibromomethylene-D-homopregna-4,16-diene-3,20-dione.
Eksempel 5.Example 5
17aa-Acetoxy-D-homopregna-4,16-dien-3,20-dion omdannes i ether ved hjælp af eddikesyreanhydrid og perchlorsyre til 3,17aa-diacetoxy-D-^ -homopregna-3,5,16-trien-20-on, og denne omsættes derefter i vandig eddikesyre med chlor i nærværelse af kaliumacetat til dannelse af 17aa-acetoxy-6-chlor-D-homopregna-4,16-dien—3,20-dion. Smeltepunkt 199 - 200°C (ether).17aa-Acetoxy-D-homopregna-4,16-diene-3,20-dione is converted into ether by acetic anhydride and perchloric acid to 3,17aa-diacetoxy-D- ^ -homopregna-3,5,16-triene-20 -one, which is then reacted in aqueous acetic acid with chlorine in the presence of potassium acetate to give 17aa-acetoxy-6-chloro-D-homopregna-4,16-diene-3,20-dione. Melting point 199 - 200 ° C (ether).
Eksempel 6.Example 6
Til en opløsning af 4 g 17act-hydroxy-D-homo-19-norpregna-4,16-dien--3,20-dion i 40 ml eddikesyreanhydrid og 40 ml triethylamin sættes 0,5 g 4-dimethylaminopyridin, og der omrøres ved 25"C. Efter 24 timers forløb hældes blandingen ud på iskold IN saltsyreopløsning og eKstraheres med ether. Efter to ganges vask med vand, tørring over. natriumsulfat og inddampning på rotationsfordamper fås 7 g råprodukt, som adsorberes på 200 g silicagel. Ved eluering med dichlormethan fås·2,5 g 17aa-acetoxy-D-homo-19-norpregna-4,16-dien-3,20-dionj smeltepunkt 210 - 212°C (dichlormethan-ether-hexan) ; ^)539 = “196° (c 11 0,100 i dioxan).To a solution of 4 g of 17act-hydroxy-D-homo-19-norpregna-4,16-diene - 3,20-dione in 40 ml of acetic anhydride and 40 ml of triethylamine is added 0.5 g of 4-dimethylaminopyridine and stirred. After 25 hours, the mixture is poured onto ice cold 1N hydrochloric acid solution and extracted with ether. After twice washing with water, drying over sodium sulfate and evaporation on a rotary evaporator, 7 g of crude product is obtained, which is adsorbed on 200 g of silica gel. with dichloromethane is obtained · 2.5 g of 17aa-acetoxy-D-homo-19-norpregna-4,16-diene-3,20-dionej melting point 210 - 212 ° C (dichloromethane-ether-hexane); 196 ° (c 11 0.100 in dioxane).
12 1/U947 17aa-Acetoxy-D-homo-19-norpregna-4,16-dien-3,20-dion kan også fremstilles ud fra 17aa-acetoxy-3,3-(ethylendioxy)-D-homo-19-norpregna--5(10),16-dien-20-on i analogi med den nedenfor beskrevne hydrolyse af 3,3-(ethylendioxy)-17aa-hydroxy-D-homo-19-norpregna-5(10),16--dien-20-on til dannelse af 17aa-hydroxy-D-homo-19-norpregna-4,16--dien-3,20-dion.12 1 / U947 17aa-Acetoxy-D-homo-19-norpregna-4,16-diene-3,20-dione can also be prepared from 17aa-acetoxy-3,3- (ethylenedioxy) -D-homo-19 norpregna - 5 (10), 16-diene-20-one by analogy with the hydrolysis of 3,3- (ethylenedioxy) -17aa-hydroxy-D-homo-19-norpregna-5 (10), 16- -diene-20-one to form 17aa-hydroxy-D-homo-19-norpregna-4,16 - diene-3,20-dione.
Fremstilling af udgangsmaterialet: I en opløsning af 27,7 ml N-cyclohexylisopropylamin i 100 ml tetrahydrofuran røres ved -78“C under argonatmosfære 76,5 ml af en ca. 20 - 25%'s opløsning af n-butyllithium i hexan. 150 ml af denne opløsning røres i løbet af 2 timer under argonatmosfære i en til -78°C afkølet opløsning af 20 g D-homoestronmethylether i 100 ml di- · chlormethan. Efter yderligere 2 timers omrøring ved -78"C tilsættes en opløsning af 10 g ammoniumchlorid i 50 ml vand, den vandige fase indstilles på sur reaktion-ved tilsætning af IN saltsyreopløsning, og der ekstraheres med dichlormethan. Efter vask med mættet hydrogen-carbonatopløsning og med vand og tørring over natriumsulfat inddampes -‘opløsningen til tørhed på rotationsfordamper. Råproduktet opløses i 100 ml toluen og opvarmes i 4 timer under tilbagesvaling, og ind-dampningsremanensen adsorberes på 600 g silicagel 0,06 - 0,2 mm; ved eluering med hexan-ethylacetat i forholdet 9:1 fås 20,8 g (90% åf dét teoretiske) 17aa-chlor-3-methoxy-D-homoestra-l,3,5(10)--trien-17ap-carboxaldehyd, smeltepunkt 116 - 117°C (dichlormethan--hexan) ; ^539 = "5° (c = 0,101 i dioxan) .Preparation of the starting material: In a solution of 27.7 ml of N-cyclohexylisopropylamine in 100 ml of tetrahydrofuran, stir at -78 ° C under an argon atmosphere 76.5 ml of a ca. 20-25% solution of n-butyllithium in hexane. 150 ml of this solution is stirred for 2 hours under an argon atmosphere in a solution cooled to -78 ° C of 20 g of D-homoestrone methyl ether in 100 ml of dichloromethane. After a further 2 hours of stirring at -78 ° C, a solution of 10 g of ammonium chloride in 50 ml of water is added, the aqueous phase is adjusted to acidic reaction by addition of 1N hydrochloric acid solution and extracted with dichloromethane. After washing with saturated hydrogen carbonate solution and The crude product is dissolved in 100 ml of toluene and heated for 4 hours under reflux and the evaporation residue is adsorbed on 600 g of silica gel 0.06 - 0.2 mm; 9: 1 hexane-ethyl acetate gives 20.8 g (90% of theory) of 17aa-chloro-3-methoxy-D-homoestra-1,3,5 (10) - triene-17ap-carboxaldehyde, m.p. 116 - 117 ° C (dichloromethane - hexane); 539 = 5 ° (c = 0.101 in dioxane).
Til en opløsning af 20,8 g 17aa-chlor-3-methoxy-D-homoestra-l,3,5(10)— -trien-17a3-carboxaldehyd i 25 ml hexamethylphosphorsyretriamid sættes 2,5 g lithiumchlorid, og der omrøres i 12 timer ved 50°C under portionsvis tilsætning af 5 g natriumhydrogencarbonat lidt efter lidt. Efter henstand natten over ved 25°C tilsættes ether, vaskes tre gange med vand og en gang med mættet hydrogencarbonatopløsning, tørres over natriumsulfat og inddampes på rotationsfordamper. Remanensen adsorberes på 1 kg silicagel, 0,06 - 0,2 mm; ved eluering med dichlormethan fås 10,1 g (50% af det teoretiske) 3-methoxy-D-homoestra-l,3,5(10) -17“tetraen-17a-carboxaldehyd; smeltepunkt 126 - 127°C (acetone-ether); Ca]589 “ +207° (c = 0,100 i dioxan).To a solution of 20.8 g of 17aa-chloro-3-methoxy-D-homoestra-1,3,5 (10) -triene-17a3-carboxaldehyde in 25 ml of hexamethylphosphoric triamide is added 2.5 g of lithium chloride and stirred. 12 hours at 50 ° C with portion addition of 5 g of sodium bicarbonate gradually. After standing overnight at 25 ° C, ether is added, washed three times with water and once with saturated hydrogen carbonate solution, dried over sodium sulfate and evaporated on a rotary evaporator. The residue is adsorbed on 1 kg of silica gel, 0.06 - 0.2 mm; eluting with dichloromethane gives 10.1 g (50% of theory) of 3-methoxy-D-homoestra-1,3,5 (10) -17 "tetraene-17a-carboxaldehyde; mp 126 - 127 ° C (acetone ether); Ca] 589 ° + 207 ° (c = 0.100 in dioxane).
13 14494713 144947
Til en opløsning af 18 g 3-methoxy-D-homoestra-l,3,5(10),17-tetra-en-17a-carboxaldehyd i 250 ml absolut tetrahydrofuran dryppes under omrøring ved 0°C og under argonatmosfære 45 ml af en ca. 2M opløsning af methyllithium i ether. Efter 2 timers forløb tilsættes vandig ammoniumchloridopløsning, og der ekstraheres fire gange med ether.To a solution of 18 g of 3-methoxy-D-homoestra-1,3,5 (10), 17-tetra-ene-17a-carboxaldehyde in 250 ml of absolute tetrahydrofuran is added dropwise with stirring at 0 ° C and under 45 ml of argon atmosphere. and approx. 2M solution of methyl lithium in ether. After 2 hours, aqueous ammonium chloride solution is added and extracted four times with ether.
De organiske faser vaskes to gange med sodå, tørres over natriumsulfat og inddampes på rotationsfordamper. Råproduktet opløses i 400 ml tert.butanol og 400 ml tetrahydrofuran og dryppes til 1,2 liter vandfri ammoniak. Til den kogende opløsning sættes portionsvis 6,1 g natrium. Efter 2 1/2 time afdestilleres ammoniakken, og reaktionsblandingen inddampes på rotationsfordamper og fordeles mellem ether og vand. Efter tørring over natriumsulfat inddampes på rotationsfordamper. Inddampningsremanensen opløses i 50 ml dichlormethan, tilsættes 100 ml ethylenglyccl og 25 ml iseddike og omrøres i 18 timer ved.25°C. Blandingen hældes ud på iskold 3N natriumhydroxidopløsning, ekstraheres med ether og inddampes på rotationsfordamper efter vask med vand og tørring over natriumsulfat. Råproduktet opløses i 100 ml pyridin og tilsættes ved 0 - 5°C 200 ml af en ca. 1M opløsning af chromtrioxid i pyridin-vand i forholdet 10:1. Efter omrøring ved 25°C i 4 timer tilsættes 5 ml ethanol, og der inddampes på rotationsfordamper. Til remanensen sættes 500 ml ether og 300 ml vand, og der isoleres ved sugefiltrering over "Speedex". Den organiske fase af filtratet vaskes med vand, tørres over natriumsulfat og inddampes på rotationsfordamper, hvorefter den adsorberes på 500 g silicagel, 0,06 - 0,2 irmw og med dichlormethan + 0,5 - 1% methanol elueres 10,5 g rent 3,3-(ethylendioxy)-D-homo-19-norpregna-5(10),17-dien--20-on; smeltepunkt 147 - 148°C (ether-hexan); C5Q9 = +238° (c = 0,101 i dioxan).The organic phases are washed twice with soda, dried over sodium sulfate and evaporated on a rotary evaporator. The crude product is dissolved in 400 ml of tert-butanol and 400 ml of tetrahydrofuran and dripped to 1.2 liters of anhydrous ammonia. To the boiling solution is added portionwise 6.1 g of sodium. After 2 1/2 hours, the ammonia is distilled off and the reaction mixture is evaporated on a rotary evaporator and partitioned between ether and water. After drying over sodium sulfate, evaporate on rotary evaporator. The evaporation residue is dissolved in 50 ml of dichloromethane, 100 ml of ethylene glycol and 25 ml of glacial acetic acid are added and stirred for 18 hours at 25 ° C. The mixture is poured onto ice-cold 3N sodium hydroxide solution, extracted with ether and evaporated on a rotary evaporator after washing with water and drying over sodium sulfate. The crude product is dissolved in 100 ml of pyridine and 200 ml of an approx. 1M solution of chromium trioxide in 10: 1 pyridine-water. After stirring at 25 ° C for 4 hours, 5 ml of ethanol is added and evaporated on rotary evaporator. To the residue are added 500 ml of ether and 300 ml of water and isolated by suction filtration over "Speedex". The organic phase of the filtrate is washed with water, dried over sodium sulfate and evaporated on a rotary evaporator, then adsorbed on 500 g of silica gel, 0.06 - 0.2 µmw and with dichloromethane + 0.5 - 1% methanol eluted 10.5 g 3,3- (ethylenedioxy) -D-homo-19-norpregna-5 (10), 17-diene - 20-one; mp 147 - 148 ° C (ether-hexane); C5Q9 = + 238 ° (c = 0.101 in dioxane).
En opløsning af 5,5 g 3,3-(ethylendioxy)-D-homo-19-norpregna-5(10),17--dien-20-on i 25 ml tetrahydrofuran dryppes til en blanding af 15 ml tert.butanol, 25 ml dimethylformamid og 2,5 ml trimethylphosphit. Opløsningen afkøles til -25“C, tilsættes 1,3 g kalium-tert.butylat og omrøres kraftigt i en oxygenatmosfære. I løbet af 25 minutter forbruges 360 ml oxygen. Blandingen hældes ud på isvand og ekstraheres med ether. Efter vask med vand, tørring over natriumsulfat og inddampning på rotationsfordamper forenes råproduktet med 2,3 g af et identisk råprodukt og adsorberes på 250 g silicagel, 0,06 - 0,2 mm; ved eluering med hexan-ethylacetat i forholdet 4:1 fås 4,18 g amorft 3,3-(ethylendioxy)-17aa-hydroxy-19-norpregna-5(10),16-dien--20-on.A solution of 5.5 g of 3,3- (ethylenedioxy) -D-homo-19-norpregna-5 (10), 17-dien-20-one in 25 ml of tetrahydrofuran is added dropwise to a mixture of 15 ml of tert.butanol , 25 ml of dimethylformamide and 2.5 ml of trimethylphosphite. The solution is cooled to -25 ° C, 1.3 g of potassium tert-butylate is added and stirred vigorously in an oxygen atmosphere. In 25 minutes, 360 ml of oxygen is consumed. The mixture is poured onto ice water and extracted with ether. After washing with water, drying over sodium sulfate and evaporation on a rotary evaporator, the crude product is combined with 2.3 g of an identical crude product and adsorbed on 250 g of silica gel, 0.06 - 0.2 mm; by elution with hexane-ethyl acetate in a 4: 1 ratio, 4.18 g of amorphous 3,3- (ethylenedioxy) -17aa-hydroxy-19-norpregna-5 (10), 16-diene-20-one is obtained.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK32077A DK144947C (en) | 1974-10-07 | 1977-01-26 | ANALOGY PROCEDURE FOR PREPARING D-HOMOPREGNA-4,16-DIEN-3,20-DIONES |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1342474A CH606112A5 (en) | 1974-10-07 | 1974-10-07 | Hormonally active D-homosteroids |
CH1342474 | 1974-10-07 | ||
CH1595074 | 1974-12-02 | ||
CH1595074 | 1974-12-02 | ||
DK123075A DK143758C (en) | 1974-10-07 | 1975-03-24 | ANALOGY PROCEDURE FOR PREPARING D-HOMOPREGNA-4,6,16-TRIEN-3,20-DIONES |
DK123075 | 1975-03-24 | ||
DK32077 | 1977-01-26 | ||
DK32077A DK144947C (en) | 1974-10-07 | 1977-01-26 | ANALOGY PROCEDURE FOR PREPARING D-HOMOPREGNA-4,16-DIEN-3,20-DIONES |
Publications (3)
Publication Number | Publication Date |
---|---|
DK32077A DK32077A (en) | 1977-01-26 |
DK144947B true DK144947B (en) | 1982-07-12 |
DK144947C DK144947C (en) | 1982-11-29 |
Family
ID=27429493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK32077A DK144947C (en) | 1974-10-07 | 1977-01-26 | ANALOGY PROCEDURE FOR PREPARING D-HOMOPREGNA-4,16-DIEN-3,20-DIONES |
Country Status (1)
Country | Link |
---|---|
DK (1) | DK144947C (en) |
-
1977
- 1977-01-26 DK DK32077A patent/DK144947C/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK32077A (en) | 1977-01-26 |
DK144947C (en) | 1982-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005311060B2 (en) | A process for the preparation of 17-hydroxy-6beta,7beta;15beta,l6beta-bismethylene-17alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process | |
US3947478A (en) | Alkylated 3,20-diketo-Δ4 -steroids of the pregnane series | |
IE62277B1 (en) | "9-Alpha-hydroxy-17-methylene steroids, process for their preparation and their use in the preparation of corticosteroids" | |
CH533094A (en) | Cpds. (I) where R1, R2, R3 = H, Me; R4 = H, cyclopropyl, or aliphatic hydrocarbon (claims only alkyl), alkenyl, alkynyl, and haloalkynyl (all 1-6C)); R5 | |
US3445489A (en) | 9beta,10alpha-steroids,intermediates therefor and pharmaceutical preparations containing these compounds as an active ingredient | |
US3682983A (en) | Preparation of {66 {11 {11 -17 ethinyl steroids | |
US2768189A (en) | Method of producing alpha-brominated keto steroid compounds | |
GB1579298A (en) | 17a-hydroxypropyl-4-3-keto-steroids and esters and ethers thereof and process for their manufactgure | |
NO164677B (en) | PROCEDURE FOR SELECTIVE CREATION OF A FLUID BAR. | |
NO146682B (en) | SEALING MATERIAL FOR ISOLATED PIPE PIPES | |
US3475464A (en) | Process for the preparation of steroids and novel intermediates thereof | |
US3972906A (en) | Novel - 11-substituted steroids of the estrane series | |
US3438975A (en) | 15alpha,16alpha-methylene pregnanes and 19-nor-pregnanes | |
DK144947B (en) | ANALOGY PROCEDURE FOR PREPARING D-HOMOPREGNA-4,16-DIEN-3,20-DIONES | |
US3579509A (en) | Process and 6-beta-substituted ethyl intermediates for preparing 6,6-ethylene-3-keto-delta**4 steroids | |
US3636011A (en) | 11beta-fluoro-19-nor-steroids and process for their preparation | |
US3258471A (en) | Process for the preparation of delta1,3,5(10)-and delta1,3,5(10),9(11)-steroids | |
US4092310A (en) | Difluorosteroids and processes for their manufacture | |
US3954980A (en) | Chemical compounds | |
US3408369A (en) | 2-substituted-3-keto-delta4, 6-9beta, 10alpha-steroids | |
IE43305B1 (en) | Steroidal naphthalenes | |
US3453295A (en) | Process for preparing 3-keto-19-nor-delta**4,9(10) steroids | |
US3419550A (en) | Pentacyclic steroid intermediates and method of preparing the same | |
US3767685A (en) | Novel 11beta-halo-steroids of the oestrane series | |
US3591582A (en) | Process for preparing alpha-acyloxy ketone steroids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |